Understand or prevent a condition.
Fourteen hot flashes a day is about one every waking hour. That was roughly the starting point for 796 menopausal women in two randomized trials, and a once-daily pill containing no hormones cut moderate to severe episodes by about three… Read More →
Two years of a structured program combining exercise, brain-healthy eating, computer brain training and social engagement was linked to larger gains in memory and thinking than self-guided change, in a randomized trial of 2,111 older adults at risk of cognitive… Read More →
An earlier look at the EMBARK trial had already shown that adding enzalutamide to standard hormone therapy delayed the spread of recurrent prostate cancer. The harder question was whether men lived longer. In the final survival analysis of this phase… Read More →
The peanut eating stopped at age 5. Children in the LEAP trial then ate peanut freely or not at all, as they pleased, and many went long stretches without any. The protection did not fade. At age 12, the children… Read More →
People who had quit smoking 10 or more years earlier lived about as long as those who never smoked, regaining roughly 10 of the 12 to 13 years of life that continued smoking was linked to losing. The figures come… Read More →
Extra minutes did not buy men what fewer minutes bought women. Men's risk of death from any cause kept falling until about 300 minutes a week of moderate-to-vigorous activity, where it bottomed out at roughly 18% below inactive men. Women… Read More →
Blood pressure treatment has long aimed at getting the top number under 140. A randomized trial of 11,255 adults tested a target of under 120 instead, and over 3.4 years the lower target produced 12% fewer major heart and blood-vessel… Read More →
Until recently, confirming Alzheimer's disease meant a spinal tap or a specialized brain scan, and most people being evaluated for memory problems never receive either. A simple blood test correctly identified whether Alzheimer's was present or absent in about 85%… Read More →
Among 2,134 young women given a twice-yearly injection, not one infection occurred. Among 2,179 men and gender-diverse adults given the same injection, there were two. Those are the HIV results of two large international trials of a drug called lenacapavir.… Read More →
